PCSK9 and atherosclerosis: Furthermore, PCSK9 siRNA induces inhibition of PCSK9, and inflammatory mediators involved in the pathogenesis of atherosclerosis IL-1α, IL-6, and TNF-α in oxLDL-stimulated THP-1-derived macrophages via suppression of NF-κB nuclear translocation [137].